Back to search

Article

Transcriptional Blood Signatures for Active and Amphotericin B Treated Visceral Leishmaniasis in India

2019-02-18

Abstract excerpt

Amphotericin B provides improved therapy for visceral leishmaniasis (VL) caused by Leishmania donovani , with single dose liposomal-encapsulated Ambisome providing the best cure rates. The VL elimination program aims to reduce the incidence rate in the Indian subcontinent to <1/10,000 population/year. Ability to predict which asymptomatic individuals (e.g. anti-leishmanial IgG and/or Leishmania-specific modified...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5e4bb89d-e24b-54c5-b302-4216da47d836
DOI
10.1101/554022
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Transcriptional Blood Signatures for Active and Amphotericin B Treated Visceral Leishmaniasis in IndiaDOI 10.1101/554022
Select a neighboring publication to make it the new centre.